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Abstract
Background: Emerging evidence suggests intensity of perinatal care influences survival for extremely preterm
babies. We evaluated the effect of differences in perinatal care intensity between centres on sensorimotor morbidity
at 2 years of age. We hypothesised that hospitals with a higher intensity of perinatal care would have improved
survival without increased disability.
Methods: Foetuses alive at maternal admission to a level 3 hospital in France in 2011, subsequently delivered
between 22 and 26 weeks gestational age (GA) and included in the EPIPAGE-2 national prospective observational
cohort study formed the baseline population. Level of intensity of perinatal care was assigned according to hospital of
birth, categorised into three groups using ‘perinatal intensity’ ratios (ratio of 24–25 weeks GA babies admitted to
neonatal intensive care to foetuses of the same GA alive at maternal admission to hospital). Multiple imputation was
used to account for missing data; hierarchical logistic regression accounting for births nested within centres was then
performed.
Results: One thousand one hundred twelve foetuses were included; 473 survived to 2 years of age (126 of 358 in
low-intensity, 140 of 380 in medium-intensity and 207 of 374 in high-intensity hospitals). There were no differences in
disability (adjusted odds ratios 0.93 (95% CI 0.28 to 3.04) and 1.04 (95% CI 0.34 to 3.14) in medium- and high- compared
to low-intensity hospitals, respectively). Compared to low-intensity hospitals, survival without sensorimotor disability
was increased in the population of foetuses alive at maternal admission to hospital and in live-born babies, but there
were no differences when considering only babies admitted to NICU or survivors.
Conclusions: No difference in sensorimotor outcome for survivors of extremely preterm birth at 2 years of age was
found according to the intensity of perinatal care provision. Active management of periviable births was associated
with increased survival without sensorimotor disability.
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Background
Extremely preterm infants, defined as those born at a
gestational age (GA) between 22 and 26 weeks, repre-
sent 0.2–0.3% of all births [1, 2] but remain at high risk
of mortality, neonatal morbidity and later developmen-
tal disorders [3, 4]. Evidence-based management has been
shown to improve outcomes of these babies. Strategies
include medical treatments like administration of ante-
natal steroids, appropriate early respiratory management
and prevention of neonatal hypothermia following deliv-
ery, as well as organisational changes to promote delivery
in a unit with appropriate neonatal facilities [5].
It is recognised that decision-making is important in
determining outcome. Case selection occurs in the deliv-
ery room [6], and there is international variability in man-
agement of (threatened) extremely preterm deliveries. For
example, national guidelines in the UK, north American
and Scandinavian countries are more likely to recommend
proactive or individualised care; other countries recom-
mend comfort care or have no recommendations [7, 8].
A study looking at hospital-level aggregates of treatments
provided to a population of live-born babies demonstrated
improvements in survival and survival without severe
morbidity in babies of 22 and 23 weeks receiving ‘active’
care following delivery when compared with the entire
population of babies born at those gestations [9].
Case selection also occurs antenatally [10]. It has there-
fore been proposed that a ‘foetuses-at-risk’ approach
should be adopted to minimise potential bias [11–13].
Evidence regarding the influence of intensity of perina-
tal care—that is, the degree to which women who deliver
extremely preterm and their offspring receive ‘active’
management—on survival andmorbidity outcomes is lim-
ited: only one study has examined this question. Indices
of obstetric and neonatal treatments were created at a
regional level using data from the Swedish EXPRESS
cohort; survival and morbidity-free survival at 2.5 years of
age were better in the more active regions [14]. Yet active
management represents more than just treatment: as well
as easily quantifiable measures (e.g. the proportions of
women receiving antenatal steroids or babies intubated at
delivery), there are underlying intentions to treat. These
are difficult to assess and not necessarily accounted for
by measuring treatments provided. Furthermore, indices
based on treatments are difficult to transpose between
studies due to differences in which data are collected and
how.
The French EPIPAGE-2 national cohort collected data
on all extremely preterm births in 2011 and will follow
up survivors until 12 years of age [15]. French guidelines
advise that perinatal management is based on assessment
of the individual’s situation at 24 and 25 weeks gestation
[16, 17]. Below 24 weeks, palliative care is recommended
[17], whereas at 26 weeks, most babies are admitted
to intensive care [2]. EPIPAGE-2 demonstrated national
rates of survival to discharge of 31% and 60% of babies
born at 24 and 25 weeks GA, respectively; 79% of live-
born babies were born in a level 3 centre [2, 18]. Results
at 2 years corrected age were recently published [4].
These were based on physician assessment of sensorimo-
tor status, as well as parentally reported Ages and Stages
Questionnaire which is a screening tool for child neurode-
velopmental status, including both intellectual/cognitive
as well as motor abilities [19].
We decided to investigate the effects of variation in the
intensity of active perinatal care at a hospital level using
the EPIPAGE-2 cohort. Our objective was to evaluate this
with a simple metric based upon readily available vital sta-
tus data relating to births at 24 and 25 weeks of gestation
and to assess the impact on objective outcomes available
at 2 years of age—namely, physician-assessed sensorimo-
tor disability and survival. We hypothesised that hospitals
with a higher level of intensity of perinatal care would
not have increased levels of sensorimotor morbidity com-
pared with hospitals of lower intensity levels.
Methods
Study population
Methods of case identification, data capture and other
design aspects for the EPIPAGE-2 cohort have been
described previously [15]. All births in France between
22 and 26 completed weeks of gestation (i.e. 26 weeks
and 6 days or fewer) occurring over an 8-month period
in 2011 were included [15]. For this study, the popu-
lation was restricted to mothers where the foetus was
alive at admission to hospital and at either the start
of monitoring of the labour or when it was decided
to perform caesarean section. Foetuses with congenital
lethal malformations and terminations of pregnancy for
congenital anomalies were excluded. All births at 22 to
26 weeks gestation occurring in a level 3 hospital [20]
with at least one delivery at 24 or 25 weeks gestation were
included.
Outcomes
The primary outcome was sensorimotor deficiency at
2 years of age among survivors. This consisted of the
adverse findings of sensory disability (blindness in one or
both eyes and/or unilateral or bilateral deafness) or cere-
bral palsy (assessed by the attending physician and defined
according to the diagnostic criteria of the Surveillance
of Cerebral Palsy in Europe (SCPE) network with inde-
pendent review of ambiguous cases by a committee of
experts) [4]. The beneficial outcome of survival without
sensorimotor deficiency was considered as a secondary
outcome. We assessed this in four populations: foetuses
alive at maternal admission to hospital, live births, babies
admitted to neonatal intensive care and survivors.
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Intensity of active perinatal care
We categorised the care provided by teams at differ-
ent hospitals into three groups using ‘perinatal intensity’
ratios based on the number of babies of 24–25 weeks ges-
tation admitted into neonatal intensive care divided by the
number of foetuses alive at maternal admission to hospi-
tal and subsequently delivered at 24–25 weeks gestation.
We identified the 25th and 75th percentile limits around
the average intensity, weighted according to the number of
viable foetuses admitted to hospital [21]. This accounted
for increased variability around the estimates for hospi-
tals with few admissions (thus addressing the concern that
the intensity ratio for the smaller hospitals may be impre-
cise). These limits were used to create ‘low’-, ‘medium’-
and ‘high’-intensity groups of hospitals, as shown in Fig. 1;
subjects were assigned according to their hospital of birth.
Detailed methods are provided in Additional file 1.
Potential explanatory variables
Data were also available for maternal, pregnancy and
neonatal factors.
Maternal characteristics considered were as follows: age
(less than 20, 20–24, 25–29, 30 and over), parity (num-
ber of previous viable births), country of birth (France
or another country) and socioeconomic status (defined
according to the highest occupational status of both par-
ents or mother only if it was a single-parent family). In
relation to the current pregnancy, there was information
on fertility treatment, singleton or multiple pregnancy,
foetal sex, presence of clinically diagnosed chorioam-
nionitis, whether there was preterm prolonged rupture
of membranes (pPROM, defined as occurring more than
12 h prior to delivery), if there was a spontaneous onset
of labour, length of maternal admission prior to delivery
(days), gestational age at delivery (in completed weeks
gestation) and foetal presentation. For babies, birth weight
z-score (using French ‘EPOPé’ intrauterine growth curves
[22]) was available.
Data relating to perinatal management (antenatal
steroids, tocolysis, in utero transfer, magnesium sulphate,
maternal antibiotic therapy, mode of delivery and neona-
tal resuscitation) were also available but were not used as
they were considered to be constituents of the exposure.
Statistical methods
Crude associations of the potential explanatory variables
were identified through cross-tabulation with perinatal
intensity levels. In order to assess the validity of our peri-
natal intensity level indicator, we also examined associa-
tions with the variables relating to perinatal management.
Multilevel logistic regression analysis using clustering at
the level of the hospital was then performed between the
assigned intensity level and the outcome to provide an
unadjusted estimate of the association. This model was
amended by sequentially adding gestational age at delivery
(model 2), multiple pregnancy status (model 3) and then
extra variables considered to be potential confounders.
These were identified a priori as potentially of impor-
tance: maternal age, family socio-economic status, fertility
treatment during the current pregnancy, chorioamnioni-
tis, pPROM, spontaneous labour, foetal sex and foetal size
at delivery.
Analyses for sensorimotor deficiency were conducted
for babies surviving to 2 years of age. We analysed both
Fig. 1 Intensity of perinatal care at 24–25 weeks gestation in French level 3 hospitals. Perinatal intensity is calculated as the ratio of babies born at
24–25 weeks gestational age who were admitted into neonatal intensive care divided by the number of foetuses delivered at the same gestational
age who were alive at maternal admission to hospital or when the decision to perform caesarean section was made; weighted average intensity is
indicated with a dashed line, 25th and 75th percentile limits with dotted lines
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complete cases and, due to missing data, imputed data
sets. For survival without sensorimotor deficiency, all
analyses used imputed data. First, we used the entire
population of foetuses alive at maternal admission. As
longer term survival in this population is likely to be
closely linked to the exposure, we repeated analyses in
the populations of babies who were born alive and in
those subsequently admitted into neonatal intensive care,
as well as in those who survived to 2 years of age. Sensi-
tivity analyses were performed for primary and secondary
outcomes using a restricted population of only those
babies that were delivered between 24 and 26 weeks ges-
tational age. All investigations were conducted using R
version 3.3.3 [23]. A p value < 0.05 was considered sta-
tistically significant throughout. Multiple imputation was
performed using chained equations with the R package
‘mice’ [24] and included variables potentially predicting
non-response or the outcome as described previously [4];
full details are in Additional file 2.
Results
Consent was provided for 3046 of 3261 births at 22–26
weeks gestation born in France. A further 1925 foetuses
were excluded as they did not meet the inclusion criteria
(Fig. 2), leaving 1121 whowere alive at maternal admission
to hospital and subsequently delivered at 22–26 weeks
gestation. Of these, nine babies were born in one of three
level 3 hospitals with no births at 24–25 weeks gestation.
Thus, 1112 babies were included: 358 were born in one of
the 19 hospitals categorised as low intensity, 380 in one of
the 20 medium-intensity hospitals and 374 in the 23 high-
intensity hospitals. Below 24 weeks gestation, there was
only one survivor (born at 23 weeks and 6 days); hence,
this child was included with those born at 24 weeks ges-
tation for the main analyses but excluded from sensitivity
analyses. The mean weighted intensity ratio was 64.3%,
with hospital ratios ranging from 0 to 100% based on a
range of 1 to 31 foetuses whowere alive atmaternal admis-
sion and subsequently delivered at 24 or 25 completed
weeks gestation (Fig. 1).
There were important associations between perinatal
intensity and perinatal management (Table 1). Antenatal
steroids and tocolysis were more frequently administered
in hospitals with a higher intensity level of perinatal care.
Babies were more likely to be resuscitated in these hos-
pitals. There were no differences in the administration of
magnesium sulphate or proportions of women transferred
in utero.
In univariate analysis, intensity of perinatal activity was
strongly associated with gestational age at delivery, with
hospitals of lower intensity having relatively higher num-
bers of babies born at 22 to 24 weeks gestation compared
to hospitals with higher intensity. There was little dif-
ference in maternal length of stay prior to delivery, the
Fig. 2 Study population. Flow chart of included study population:
EPIPAGE-2 cohort at 2 years corrected age
numbers of singleton or multiple pregnancies or in mater-
nal age profiles, but mothers were less likely to have had
fertility treatment in low-intensity hospitals (p = 0.03):
14.7% compared to 20.5% and 22.1% in medium- and
high-intensity units, respectively. Family socioeconomic
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Table 1 Factors associated with active perinatal care according




n % n % n %
Antenatal steroids (N = 1042)
No 166 50.3 146 40.4 92 26.2 < 0.001
Yes 164 49.7 215 59.6 259 73.8
In utero transfer (N = 1059)
No 191 55.2 200 55.0 169 48.4 0.12
Yes 155 44.8 164 45.0 180 51.6
Tocolysis (N = 1057)
No 191 55.0 152 42.1 122 35.0 < 0.001
Yes 156 44.0 209 57.9 227 65.0
MgSO4 usage (N = 1045)
No 322 93.1 340 95.5 324 94.5 0.37
Yes 24 6.9 16 4.5 19 5.5
Mode of delivery (N = 946)
Caesarean 91 31.7 124 37.9 125 37.6 0.20
Vaginal 196 68.3 203 62.1 207 62.4
Baby resuscitated (N = 803)
No 74 31.2 37 14.1 32 10.6 < 0.001
Yes 163 68.8 226 85.9 271 89.4
status and the presence of pPROM also varied between
groups. Complete data are shown in Table 2.
Sensorimotor outcome at 2 years of age
Physician response rates to sensorimotor assessment at
2 years of age were 85.7%, 82.1% and 82.6% in the low-,
medium- and high-intensity groups respectively. There
were no statistically significant differences between the
groups in the level of sensorimotor disability, with rates
ranging from 5.8 to 7.0% (p = 0.9, Table 3). Complete case
analysis did not demonstrate any differences in disability
status for survivors who were born in hospitals of different
intensity levels. Complete data were available for 394 cases
for the baseline model and those adjusted for gestational
age and multiple status. After including all a priori pos-
tulated factors, adjusted odds ratios (OR) among the 310
complete cases were 0.67 (95% confidence interval (CI)
0.17 to 2.69) for medium- and 0.81 (95% CI 0.23 to 2.81)
for high-intensity hospitals (Table 4).
Following multiple imputation, the rates of sensorimo-
tor deficiency were slightly higher than in the complete
cases: 6.9% (95% CI 4.7 to 9.2), 7.8% (95% CI 5.5 to
10.0) and 7.3% (95% CI 5.5 to 9.1) corresponding to
low-, medium- and high-intensity groups, respectively
(Table 3). The baseline unadjusted OR was 1.13 (95% CI
0.41 to 3.17) in medium-intensity hospitals and 1.05 (95%
CI 0.39 to 2.79 in high-intensity hospitals, both compared
to hospitals with a low perinatal intensity level). There was
little change after adjustment: the fully adjusted ORs were
0.93 (95% CI 0.28 to 3.04) and 1.04 (95% CI 0.34 to 3.14)
in medium- and high-intensity centres, respectively. Full
results are in Table 4.
Morbidity-free survival
Compared to births in a low-intensity hospital, survival to
2 years of age without sensorimotor deficiency was higher
in hospitals of high perinatal intensity in the population
of foetuses who were alive at maternal admission to hos-
pital. After multiple imputation, the unadjusted OR was
2.48 (95% CI 1.62 to 3.78). Results were attenuated by
adjustment for gestational age to an OR of 2.15 (95% CI
1.37 to 3.37) and, following inclusion of all a priori consid-
ered potential confounders, remained similar. There was
no difference for babies born in hospitals with a medium
level of intensity compared to those born in low-intensity
hospitals in this population.
Among live births, there was also improved morbidity-
free survival in babies born in high-intensity hospitals: the
unadjusted odds ratio (1.97, 95% CI 1.17 to 3.33) remain-
ing significant after adjustment for all factors (adjusted
OR 1.74, 95% CI 1.05 to 2.88). There was no evidence
of a difference for babies born in a hospital of medium
intensity.
When considering only those babies who were admit-
ted into neonatal intensive care, there was no evidence of
a difference in outcome for babies born in high- (adjusted
OR 1.17, 95% CI 0.68 to 2.01) or medium- (adjusted OR
0.70, 95% CI 0.40 to 1.21) intensity hospitals compared to
those born in a hospital of low-intensity perinatal care.
Complete results for all populations are shown in Table 5.
Sensitivity analyses
Results from sensitivity analyses using populations
restricted to births from 24 to 26 weeks GA did not show
any important differences from the main analyses. Tables




This study examined the impact of the intensity of peri-
natal care on outcomes at 2 years of age for extremely
preterm babies born in French level 3 hospitals in 2011.
Among survivors, there was no evidence of a difference in
the adverse primary outcome of sensorimotor disability.
There were, however, important differences in the benefi-
cial outcome of survival without sensorimotor morbidity
for babies born in hospitals of high-intensity perinatal care
compared with those born in hospitals of low intensity
among the populations of foetuses alive at admission to
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n % n % n %
Gestational age at delivery (N = 1112)
22 39 10.9 34 8.9 30 8.0 < 0.001
23 43 12.0 50 13.2 36 9.6
24 88 24.6 79 20.8 50 13.4
25 75 21.0 103 27.1 115 30.8
26 113 31.6 114 30.0 143 38.2
Maternal length of stay prior to delivery (N = 1059)
< 24 h 259 74.6 270 74.4 246 70.5 0.59
24 to < 48 h 55 15.8 52 14.3 56 16.0
48 to < 72 h 16 4.6 20 5.5 18 5.2
72+ h 17 4.9 21 5.8 29 8.3
Multiple pregnancy (N = 1112)
No 266 74.3 258 67.9 264 70.6 0.16
Yes 92 25.7 122 32.1 110 29.4
Foetal sex (N = 1105)
Male 178 50.3 180 47.6 178 47.7 0.72
Female 176 49.7 198 52.4 195 52.3
Maternal age group (N = 1105)
< 25 years 81 22.6 65 17.1 71 19.4 0.16
25-29 years 99 27.6 121 31.8 119 32.4
30-34 years 94 26.3 123 32.4 105 28.6
≥ 35 years 84 23.5 71 18.7 72 19.6
Mother born outside of France (N = 1033)
No 239 72.9 259 74.9 261 72.7 0.78
Yes 89 27.1 87 25.1 98 27.3
Single mother (N = 1044)
Yes 38 11.2 38 10.7 38 10.8 0.97
No 300 88.8 317 89.3 313 89.2
Family SES (N = 983)
Professional 64 20.0 49 14.9 95 28.4 0.01
Intermediate 62 19.4 56 17.1 48 14.3
Administrative, public service, self-employed, students 75 23.4 101 30.8 77 23.0
Shop assistants, service workers 45 14.1 49 14.9 43 12.8
Manual workers 49 15.3 47 14.3 51 15.2
Unemployed 25 7.8 26 7.9 21 6.3
Primiparous (N = 1101)
No 161 45.6 162 43.1 159 42.7 0.70
Yes 192 54.4 214 56.9 213 57.3
Maternal fertility treatment (N = 1069)
No 291 85.3 294 79.5 279 77.9 0.03
Yes 50 14.7 76 20.5 79 22.1
pPROM (N = 1053)
No 208 60.6 212 58.4 219 63.1 0.44
Yes 135 39.4 151 41.6 128 36.9
Chorioamnionitis diagnosed < 48 h to delivery (N = 930)
No 190 65.1 221 70.4 240 74.1 0.05
Yes 102 34.9 93 29.6 84 25.9
SGA (N = 1037)
Yes 83 25.0 77 21.8 88 25.1 0.50
No 249 75.0 277 78.2 263 74.9
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n % n % n %
Spontaneous labour (N = 908)
None 64 23.1 71 22.8 76 23.8 0.96
Spontaneous 213 76.9 240 77.2 244 76.2
Spontaneous rupture of membranes (N = 981)
No 130 39.8 130 40.0 138 42.0 0.82
Yes 197 60.2 195 60.0 191 58.0
Foetal presentation (N = 924)
Cephalic 139 50.0 177 55.8 183 55.6 0.19
Breech 128 46.0 120 37.8 133 40.4
Other 11 4.0 20 6.3 13 4.0
hospital and in live births, but no differences when consid-
ering babies admitted to neonatal intensive care. Results
remained consistent in sensitivity analyses restricted to 24
to 26 weeks gestation.
Strengths and limitations of this study
Strengths of our study include the fact it is a large,
prospectively collected national cohort with standardised
definitions of outcomes following international recom-
mendations. Data collection was comprehensive [2, 4]
with an overall follow-up rate of 83.3% for the sensorimo-
tor outcome for the children included in this study. This is
better than or similar to other population cohorts at a sim-
ilar age [26, 27]. We used multiple imputation [24] to help
mitigate this issue, but ideally, follow-up would be higher
as the impact of missing data is difficult to ascertain: it is
not possible to know whether children lost to follow-up
are more or less likely to be impaired [28].
The measure of perinatal care intensity we used makes
no assumptions about appropriate or ‘best’ practices.
Instead, we assumed ‘active’ management would use any
and all appropriate available techniques to ensure the
baby survives. In the scenario we examined, this trans-
lates to hospitals providing treatment such that babies are
subsequently admitted into neonatal intensive care. Fol-
lowing maternal admission to hospital, foetal deaths prior
to delivery (stillbirths) or in the delivery room were there-
fore interpreted as a sign of inactive management. We
restricted our measure of activity to include only births at
24 to 25 weeks gestational age as these are the ages when
there was the greatest variability in practice in France in
2011: babies born before 24 weeks gestation almost uni-
formly did not receive active care, whereas at 26 weeks
gestation, the inverse was true [15, 17].
That there were very few admissions at 24 to 25 weeks
gestation in some hospitals, meaning that the indicator
was partly based on small numbers, could be a weakness.
We addressed the possible imprecision of the intensity
ratio for these hospitals by weighting the mean around
which the groups were constructed. A counter point is
that we included almost all births at 22–26 weeks gesta-
tion occurring in level 3 hospitals in France. Only three
Table 3 Numbers and percentages of participants with confidence intervals by level of intensity
Perinatal intensity level
Low Medium High
n % (95%CI) n % (95%CI) n % (95%CI)
Foetal admissions 358 – – 380 – – 374 – –
Live births 243 67.9 (62.7–72.6) 274 72.1 (67.3–76.5) 308 82.4 (78.0–86.0)
Admitted to NICU 171 47.8 (42.5–53.1) 225 59.2 (54.1–64.2) 276 73.8 (69.0–78.1)
Alive at 2 years 126 35.2 (30.3–40.4) 140 36.8 (32.0–41.9) 207 55.3 (50.1–60.4)
CP (n responding) 108 – – 115 – – 171 – –
CP/sensory deficiency 7 6.5 (2.9–13.4) 8 7.0 (3.3–13.7) 10 5.8 (3.0–10.8)
Imputed population* 126 – – 140 – – 207 – –
CP/sensory deficiency* – 6.9 (4.7–9.2) – 7.8 (5.5–10.0) – 7.3 (5.5–9.1)
*Imputed percentages were averaged across the 60 imputed data sets using Rubin’s rule [25]
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Table 4 Sensorimotor outcomes at 2 years of age among survivors of babies born at 24–26 weeks gestation in medium- and
high-intensity units compared to low-intensity units in France in 2011
Model Number
Medium intensity High intensity
OR (95% CI) OR (95% CI)
Complete cases
Unadjusted 394 1.08 (0.38–3.08) 0.90 (0.33–2.43)
Baseline + GA 394 0.84 (0.29–2.48) 0.72 (0.26–2.00)
Baseline + GA + multiple status 394 0.87 (0.29–2.62) 0.73 (0.26–2.07)
Baseline + extra variables 310 0.67 (0.17–2.69) 0.81 (0.23–2.81)
After multiple imputation
Baseline 473 1.13 (0.41–3.17) 1.05 (0.39–2.79)
Baseline + GA 473 0.95 (0.33–2.73) 0.88 (0.32–2.40)
Baseline + GA + multiple status 473 1.02 (0.35–3.01) 0.92 (0.33–2.57)
Baseline + extra variables 473 0.93 (0.28–3.04) 1.04 (0.34–3.14)
95% CI 95% confidence interval, GA gestational age, extra variables GA + multiple status + foetal sex + maternal age + family SES + fertility treatment + chorioamnionitis +
labour type + SGA + premature rupture of membranes
of 65 units did not admit any women who would sub-
sequently deliver at 24–25 weeks gestation—meaning we
were unable to calculate perinatal intensity ratios. How-
ever, between them, there were only nine deliveries at
22–26 weeks gestation in these three hospitals.
The overall size of the cohort may also be perceived
as a problem. In fact, the numbers in EPIPAGE-2 do
not differ greatly from other cohorts. The first EPI-
Cure in 1995 included 4004 births under 26 weeks
gestation with 308 survivors to 2.5 years of age in
Great Britain and Ireland over 10 months [29, 30]; the
second EPICure in 2006 included 2326 births below
27 weeks gestation with 1031 survivors to 3 years of age
in England during 1 year [26, 31]; EXPRESS reported
Table 5 Survival without sensorimotor disability at 2 years of age in populations delivered at 22–26 weeks gestation in France in 2011
Population Model
Medium intensity High intensity
OR (95% CI) OR (95% CI)
Foetuses Baseline (unadjusted) 1.08 (0.71–1.64) 2.48 (1.62–3.78)
Baseline + GA 1.06 (0.67–1.66) 2.15 (1.37–3.37)
Baseline + GA + multiple status 1.00 (0.65–1.56) 2.12 (1.36–3.29)
Baseline + GA + multiple status + extra factors 1.01 (0.63–1.61) 2.18 (1.37–3.46)
Live births Baseline (unadjusted) 1.03 (0.60–1.74) 1.97 (1.17–3.33)
Baseline + GA 0.94 (0.57–1.54) 1.77 (1.09–2.89)
Baseline + GA + multiple status 0.89 (0.55–1.45) 1.75 (1.08–2.83)
Baseline + GA + multiple status + extra factors 0.91 (0.54–1.51) 1.74 (1.05–2.88)
NICU admissions Baseline (unadjusted) 0.59 (0.35–1.02) 1.02 (0.60–1.74)
Baseline + GA 0.68 (0.40–1.17) 1.16 (0.68–1.97)
Baseline + GA + multiple status 0.66 (0.39–1.13) 1.16 (0.69–1.96)
Baseline + GA + multiple status + extra factors 0.70 (0.40–1.21) 1.17 (0.68–2.01)
Survivors Baseline (unadjusted) 0.88 (0.32–2.47) 0.95 (0.36–2.54)
Baseline + GA 1.06 (0.37–3.05) 1.14 (0.42–3.13)
Baseline + GA + multiple status 0.98 (0.33–2.88) 1.08 (0.39–3.01)
Baseline + GA + multiple status + extra factors 1.04 (0.32–3.38) 0.96 (0.32–2.86)
Foetuses foetuses (babies) alive at the onset of labour/maternal admission to hospital, GA gestational age, extra factors foetal sex + maternal age + family SES + fertility
treatment + chorioamnionitis + labour type + SGA + premature rupture of membranes
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774 births below 27 weeks gestation with 491 survivors
at 2 years of age in Sweden during a 4-year period
[27, 32]; and EPIPAGE-2 reported 2205 births below
27 weeks gestation with 545 survivors at 2 years in France
in 8 months of 2011 [2, 4]. Compared to England in 2006,
there was a higher proportion of babies born in a level
3 unit in France in 2011 (79.0% [2] compared to 56.4%
in the EPICure 2 study [33]). For comparison, there are
observational studies with larger numbers of subjects, but
these tend to have been conducted by research networks
without defined geographical coverage over a number of
years.
We also note that the distribution of gestational age at
delivery appears to differ between the intensity groups.
This may be due to the fact that women admitted to high-
intensity hospitals with threatened preterm labour are
more likely than those admitted to low-intensity hospitals
to have treatments aimed at prolonging the pregnancy—
and of delivering a liveborn baby in good condition such
that the baby is subsequently admitted to neonatal inten-
sive care. This hypothesis is supported by the associations
seen with active management treatments (e.g. tocolysis
and antenatal steroids) which were more frequently used
in women who delivered in high-intensity hospitals. How-
ever, there was no difference in overall length of maternal
admission to hospital prior to delivery. An alternative
hypothesis is, therefore, that the skewed distribution is
linked to the construction of the indicator (as it uses
babies born at both 24 and 25 weeks gestation). This does
not explain differences in the numbers of babies born at
22, 23 or 26 weeks, though, so there may be a differ-
ent reason or combination of reasons for the differences
seen. We accounted for this potential bias by including
gestational age in all adjusted analyses. Similarly, while
there were no differences in the distribution of multi-
ple pregnancies between intensity groups, we felt it was
important to account for this in our models as there was
potential for this to influence the ratios used to classify
hospitals.
Another criticism might be that the indicator used as
the exposure is contained within one of the outcomes (sur-
vival without sensorimotor disability), and thus, a positive
association is to be expected. While this may be partly
true—an ‘active’ hospital is one that has improved ‘peri-
natal’ survival (defined here as survival prior to admission
to neonatal intensive care)—our definition of intensity
only included foetuses subsequently delivered at 24 to
25 weeks gestation whereas the morbidity-free survival
outcome also included deliveries occurring at 22, 23 and
26 weeks gestation. Consequently, the results were not
certain, particularly given the high degree of variability
in the numbers of babies born in each hospital at each
week of gestation. Furthermore, intensity was measured
at the hospital level but assigned to individual subjects.
This is the same method and the same population as
previously used by investigators in the EXPRESS study
[14]. In that study, they used rates of obstetric treatments
such as administration of antenatal steroids, tocolysis and
caesarean section—all of which are strongly linked to
improved survival prior to neonatal unit admission [34]—
as contributory factors towards their ‘regional activity
score’. The EXPRESS investigators additionally performed
analyses in the live-born population, as did we. How-
ever, by investigating the population who were admitted
to neonatal intensive care, our results indicate that sur-
vival differences only occur prior to intensive care unit
admission without subsequent impact on morbidity sta-
tus. In turn, this suggests that it is not possible to identify
in the delivery room those babies who will have a better—
or worse—long-term outcome. Finally, we note that in
our study, survival was but a secondary outcome: there is
no obvious link between our measure of perinatal inten-
sity and the primary outcome of sensorimotor disability at
2 years of age.
Study findings in context
Previous studies have investigated the relationship
between the volume of admissions and outcome [33] or
between measures of activity based on individual treat-
ments such as administration of antenatal steroids, tocol-
ysis, magnesium sulphate, caesarean section or postnatal
attempts at resuscitation (for example, intubation or the
administration of surfactant) [9, 14, 35, 36]. Such indica-
tors are dependent upon the presenting circumstances of
each patient and on local management protocols. They
therefore may not be good indicators of differences in the
intensity of active perinatal management between hos-
pitals or regions due to differences in population make-
up or varying protocols. For example, tocolysis may be
of use in women who have pPROM but is not indi-
cated in the absence of active labour. Antenatal steroids
are recommended for threatened preterm delivery [37],
but there may be insufficient time prior to delivery for
administration. Both of these indicators consequently
vary according to the presenting population. There are
also differences postnatally. Some hospitals routinely intu-
bate babies born at extremely preterm gestations. Others
seek to avoid intubation altogether during the first 72 h
of life, preferring to utilise techniques such as contin-
uous positive airway pressure along with less invasive
surfactant administration via a narrow-bore endotracheal
catheter during spontaneous respiration [38]. The validity
of our indicator was additionally highlighted by show-
ing strong relationships with such perinatal management
factors.
Our investigation focused on the intensity of active peri-
natal care in hospitals, thus trying to ascertain the effect
from groups of professionals who work together on a
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daily basis. Importantly, this includes both obstetric and
neonatal elements, rather than just obstetric or neona-
tal. We are thus better able to answer the question,
‘does intensity of active perinatal care improve longer
term prognosis?’ The simplicity of the indicator means
it is easily transferable to other situations as vital status
measures are commonly made. For example, it can be
applied using different baseline gestational ages accord-
ing to local attitudes towards extremely preterm delivery.
It could be applied to regions or networks instead of hos-
pitals and is also easily transportable between cohorts. It
could also be applicable in other situations, such as the
admission of patients with head injury via the emergency
room to intensive care or adults suffering in-hospital car-
diac arrest who are subsequently admitted to a coronary
care unit.
Although there was only one survivor born below
24 weeks GA, attitudes in France towards extreme
preterm birth are not dissimilar to some other European
countries [7]. Recent studies from the Netherlands
demonstrate most variation in attitudes among obstetri-
cians and neonatologists occurring at 24 and 25 weeks
gestation [39], with significant mortality at these gesta-
tions [40]. A study comparing five different European
regions showed the largest differences in survival for
babies born at 500 g or more at 24 weeks gestation;
results for births at 23 and 25 weeks and below 500 g
were much more similar [41]. More importantly, per-
haps, there have been changes over time in attitudes to
extremely preterm birth across Europe, and hospitals that
have actively changed their policies seem to have expe-
rienced larger survival gains [42]. We also note that our
findings are consistent with those from studies in Sweden
[14] and the USA [9].
Conclusion
This study described a novel measure of the intensity
of perinatal care comprised of common vital measures
which could be applied broadly elsewhere. In this pop-
ulation of women delivering at extremely preterm gesta-
tions, we found no evidence of increased sensorimotor
impairment at 2 years of age for babies born in hos-
pitals with a higher intensity of active perinatal man-
agement. We demonstrated an important improvement
in survival without sensorimotor disability in popula-
tions of foetuses alive at maternal admission to hospital
and in live births. Together, these results indicate that
hospitals with higher perinatal intensity levels improve
survival without increasing sensorimotor morbidity at
2 years of age. They support findings from other popula-
tions that outcomes are better following higher intensity
treatment at birth and strengthen the case that more
aggressive treatment does not lead to increased levels of
morbidity.
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